NCT06997224 Effects of Triflow and Deep Breathing and Cough Exercises on Respiration in Patients Undergoing Mitral Valve Replacement
| NCT ID | NCT06997224 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Atlas University |
| Condition | Mitral Valve Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-05-15 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of breathing exercises or the use of assistive devices is to provide deep breathing after surgery and to obtain a normal breathing pattern. The purpose of choosing the method to be applied is to obtain the best result. The results of the few studies conducted on this subject are contradictory and insufficient. In this context, the purpose of this study is to compare the effects of using only triflow and using triflow together with deep breathing and cough exercises on postoperative respiratory functions in patients who underwent simultaneous tricuspid valve surgery for mitral valve.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study Literate and knowing the native language Exclusion Criteria: * Hemodynamically unstable patients, Patients who develop postoperative respiratory complications, Lip or palate anomalies
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06997224 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Mitral Valve Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06997224 currently recruiting?
Yes, NCT06997224 is actively recruiting participants. Contact the research team at caykinn@gmail.com for enrollment information.
Where is the NCT06997224 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06997224 clinical trial?
NCT06997224 is sponsored by Atlas University. The trial plans to enroll 60 participants.